Overview
A leading organization in the clinical supply trial industry, specializing in the efficient delivery of investigational medicinal products (IMPs) to patients participating in clinical studies.
INDUSTRY
Pharmaceutical
SERVICES/PLATFORMS
Implementation
Our client is a leading organization in the clinical supply trial industry, specializing in the efficient delivery of investigational medicinal products (IMPs) to patients participating in clinical studies. They rely on cutting-edge technologies and a resilient supply chain to ensure the smooth execution of clinical trials, all while prioritizing the timely and reliable delivery of life-saving therapies.
Friction Points
- Fragmented Processes and Data Silos: Limited collaboration among stakeholders due to disconnected systems resulted in low efficiency and productivity.
- Extended Planning Lead Times: These delays increased the overall study duration, exposed the supply chain to risks, and drove up costs per study and subject.
- Limited Visibility of Inventory: A lack of end-to-end transparency across the supply network created inefficiencies in managing inventory levels.
- Excessive IMP Waste: Over half of the IMP kits were wasted, significantly escalating the overall clinical trial cost.
Solution
Control Tower for Inventory Visibility:
- Implemented a centralized system providing real-time, end-to-end visibility of inventory across the supply network.
Personalized One-Stop Platform:
- Introduced a unified digital platform to streamline planning and execution, fostering seamless collaboration among all stakeholders.
Digital Twin for Real-Time Optimization:
- Created a virtual replica of the physical supply chain to monitor, predict, and optimize operations in real time, enabling proactive decision-making and scenario analysis.
Impact
- Reduction in IMP Waste: Achieved a 15%-20% decrease in wasted kits, significantly lowering trial costs.
- Enhanced Decision Accuracy: Improved decision accuracy to over 95%, ensuring more reliable planning and execution.
- Accelerated Planning: Reduced planning lead times by 25%, expediting overall study timelines.
- Minimized Dispensation Errors: Reduced missed patient dispensations to below 0.1%, ensuring timely delivery of medicines to patients.